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Microglia versus myeloid cell
nomenclature during brain
inflammation
Melanie Greter*, Iva Lelios and Andrew Lewis Croxford
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
As immune sentinels of the central nervous system (CNS), microglia not only respond
rapidly to pathological conditions but also contribute to homeostasis in the healthy brain.
In contrast to other populations of themyeloid lineage, adult microglia derive from primitive
myeloid precursors that arise in the yolk sac early during embryonic development, after
which they self-maintain locally and independently of blood-borne myeloid precursors.
Under neuro-inflammatory conditions such as experimental autoimmune encephalomyeli-
tis, circulating monocytes invade the CNS parenchyma where they further differentiate
into macrophages or inflammatory dendritic cells. Often it is difficult to delineate resident
microglia from infiltrating myeloid cells using currently known markers. Here, we will
discuss the current means to reliably distinguish between these populations, and which
recent advances have helped to make clear definitions between phenotypically similar,
yet functionally diverse myeloid cell types.
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Introduction
Most tissues are populated by incredibly diverse and abundant myeloid cells. By contrast, the central
nervous system (CNS) harbors comparatively few myeloid cell subsets. This is likely due to the
immune privilege and relative isolation enjoyed by the CNS compared to other non-lymphoid
tissues such as the gut or the lung, which are continually confronted with foreign entities. In
the steady state, the CNS houses several populations of myeloid cells with distinct localizations
including perivascular, choroid plexus, and meningeal macrophages/dendritic cells (DCs) and
microglia, which are the most abundant (1). Microglia are considered the resident macrophages
of the brain given that they are the only myeloid cells present in the CNS parenchyma. Microglia
perform both homeostatic and immune-related functions and constitute about 5–20% of all cells
in the CNS (2). They use their “ramified” morphology to act as immune sentinels, extending
specialized processes, and sampling the local environment for foreign bodies (3, 4). Numerous
recent reports have unmasked additional functions for microglia other than being simply the brain’s
intrinsic immune system. For example, microglia are also critical for neuronal development, adult
neurogenesis, learning-dependent synapse formation, and brain homeostasis (5–7). Microglia are
classified as tissue resident macrophages but are clearly ontogenically distinct from other members
of the mononuclear phagocyte system (MPS), which includes DCs, monocytes, and macrophages.
Microglia originate from primitive macrophages that derive from erythro-myeloid precursors in the
yolk sac (8–10). These primitive yolk sac macrophages colonize the developing brain in mice as
early as embryonic day 9.5 (8). Throughout adult life microglia remain of embryonic origin in the
healthy CNS and maintain themselves locally without any detectable contribution from circulating
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myeloid progenitors including monocytes. Yolk sac macrophages
and microglia precursors in the developing brain express high
levels of the fractalkine receptor (CX3CR1) and are positive for
the integrin alpha M (Itgam, also know as CD11b; macrophage-
1 antigen, Mac-1), F4/80, and the macrophage-colony stimulat-
ing factor receptor 1 (Csf-1R, CD115) similar to adult microglia
as described below (8). Compared to adult microglia, however,
microglia precursors are CD45hi. The development of microglia
is dependent on Csf-1R (CD115), the transcription factors PU.1
and Irf8 but is independent of Myb, which is crucial for the
development of hematopoietic stem cells (HSCs) (8, 9, 11, 12). In
contrast to microglia, recent adoptive transfer and fate-mapping
studies revealed that other macrophage populations are either
embryonically derived from definitive hematopoiesis (e.g., alveo-
lar or heartmacrophages) or are constantly replaced by circulating
monocytes (e.g., dermal or gut macrophages) (10, 13–18). Aside
from the unique ontogeny of microglia within the MPS, a clear
classification of microglia compared to other tissue macrophages
in terms of phenotype and function has been difficult. Only
recently, transcriptome and epigenetic analysis identified genes
uniquely expressed and regulated by microglia but not by other
macrophage populations (19–24). These studies might be useful
to classify and distinguish microglia from other myeloid cells.
Microglia Markers in Steady State
In steady state conditions, microglia express surface markers typi-
cally present onmanyother tissuemacrophages and/ormonocytes
such as CD11b, F4/80, Fc-gamma receptor 1 (CD64), and CD115
(Csf-1R), ionized calcium-binding adaptermolecule 1 (Iba-1) and
proto-oncogene tyrosine-protein kinaseMER (MerTK) (Figure 1)
(19). In contrast to microglia, which are γ-irradiation resistant,
perivascular myeloid cells are replaced by bone marrow (BM)-
derived precursors after total-body irradiation and BM transplan-
tation (25–28). However, the exact ontogeny of (non-microglia)
myeloid cells associated with the CNS and whether they are also
able to maintain themselves locally is, to date, not known (29).
These perivascular cells are equipped to present antigen (varying
levels of MHCII and CD11c). Whether they represent a homo-
geneous distinct population or a heterogeneous population of
macrophages and/orDCs is not entirely resolved. In the past, a cell
expressing F4/80 was deemed to be a macrophage, whereas a cell
expressingCD11cwas considered aDC. It is clear now that subsets
of DCs can also express F4/80 and certain macrophage popula-
tions express CD11c. Upon Flt3L treatment, a CD11c+MHCII+
population in the meninges and choroid plexus expanded, which
is indicative of the DC lineage whose development is dependent
on Flt3L signaling (27, 28). In addition, a limited number of
CD11c+ myeloid cells were also described to be in a juxtavascular
location in the CNS parenchyma (30). These cells might, however,
represent bona fidemicroglia expressing CD11c in certain regions
of the brain. Further studies are required to dissect the ontogeny
and characterize these elusive myeloid cells associated with the
CNS in the steady state.
As common to many other macrophage populations including
microglia, most of the CNS-associated myeloid cells also express
CD11b, CD115, Iba-1, and F4/80 (31). Therefore, apart from
their location, the only available means to unequivocally distin-
guish microglia from other CNS-resident myeloid populations
(CNS-associated macrophages/DCs) and circulating monocytes
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FIGURE 1 | Central nervous system myeloid cells and their defining lineage markers. In the steady state and under inflammatory conditions, myeloid cells in
the CNS express a diverse, yet overlapping set of markers commonly used to discriminate between MPS members.
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is by the reduced expression of the common leukocyte anti-
gen CD45, which is readily detectable by flow cytometry. Adult
microglia, unlike most other tissue macrophages, constitutively
express high levels of the fractalkine receptor CX3CR1 (32).
A major advance in the microglia field has been the genera-
tion of Cx3Cr1creER mice (32–34). This tamoxifen-inducible Cre-
recombinase under the CX3CR1 promoter allows for microglia-
specific gene targeting. Despite the fractalkine receptor being
expressed by monocytes and myeloid precursors in the BM,
microglia remain a self-contained population in the CNS and
therefore remain targeted long after ceasing of tamoxifen adminis-
tration, returning the short-lived, circulatingmyeloid cells to their
wild-type origin.
Only recently, gene expression studies have identified sur-
face markers and transcription factors specifically expressed by
steady state microglia but not by other macrophage popula-
tions or monocytes. These include, for example, sialic acid-
binding immunoglobulin-type lectin H (Siglec-H), Fc receptor-
like S (Fcrls), and purinergic receptor P2Y G-protein coupled 12
(P2ry12) (20, 21). Furthermore, microglia seem to be the only
hematopoietic cell population that specifically expresses Sal-like
1 (Sall1), a transcription factor that plays a crucial role in kidney
development (35). While previous studies have reported expres-
sion of Sall1 only by stromal cells, in the adult CNS this factor
is expressed exclusively by microglia. These aforementioned gene
expression studies have compared the transcriptome of microglia
to either macrophages derived from the spleen, the lung, the peri-
toneum, or to monocytes. Whether these microglia core signature
markers are also expressed by CNS-associated macrophages/DCs
remains to be shown.
Microglia Markers in Inflammation
In contrast to the healthy brain, during neuro-inflammation the
picture becomes far more complicated. A hallmark of microglia is
their rapid activation after a CNS insult, resulting in their migra-
tion toward injury, proliferation, and their change in morphology.
They take on a more “amoeboid” shape with shorter and thicker
processes, display increased immunoreactivity for Iba-1 and
upregulate CD45. Experimental autoimmune encephalomyelitis
(EAE), which is a mouse model for multiple sclerosis (MS),
is characterized by infiltration of T cells, monocytes, and neu-
trophils. Monocytes and their progeny [macrophages/monocyte-
derived DCs (moDCs)] are undoubtedly the prevailing cell type
in the lesions (see below). However, activated microglia are also
clearly detected in the vicinity of the inflammatory lesions. The
downregulation of Ly6C by monocytes upon their differentiation
adds complexity to the separation of these two distinct cell types
based on the commonly used cell surface markers. Additionally,
molecules involved in antigen presentation and T cell stimula-
tion, which are barely detectable in steady state microglia, are
expressed to some level by microglia already at disease onset and
retain expression throughout disease progression. These mark-
ers include major histocompatibility complex class II (MHCII),
CD11c (also known as integrin alpha X, Itgax), CD80 (B7-
1), CD86 (B7-2), and CD40 (36–38). Under these conditions,
it is considerably more difficult to distinguish these activated
microglia from inflammatory monocyte-derived cells. Similar
changes in microglia surface markers have been observed in
mouse models of neurodegenerative disease such as Alzheimer’s
disease (AD), Parkinson’s disease, and amyotrophic lateral sclero-
sis (ALS) (20, 31, 39).
A recent study, however, has used differentially expressed
chemokine receptors on the surface of microglia and monocytes
to distinguish those two myeloid populations and study their
function during neuro-inflammation. Microglia were identified
by their high expression of CX3CR1 whereas infiltrating mono-
cytes, which subsequently differentiate into macrophages/DCs,
were defined by their high expression of C–C chemokine receptor
type 2 (CCR2), a receptor mediating monocyte recruitment to
sites of inflammation. Gene expression profiles frommacrophages
versus “embryonically derived” microglia at different stages of
EAE show that despite some similarities between these inflam-
matory cell types, microglia exhibit a distinct molecular signa-
ture (40). This genetic distinction reflects a different function of
resident microglia and infiltrating monocytes under pathological
circumstances. While monocyte-derived macrophages seemed to
be the effector cell type causing CNS damage, microglia might
have a regulatory function and could play a role in tissue repair
and homeostasis (40). Another report also showed thatmonocytes
recruited to the CNS in EAE do not acquire microglia-signature
genes (21). These studies will unquestionably help attributing
unique functions to microglia and CNS-invading myeloid cells in
different pathological conditions in the brain.
Whether microglia-specific surface markers and transcription
factors alter their expression between steady state and inflam-
mation remains unclear. The microglia-specific ATP receptor
P2ry12 was downregulated under inflammatory conditions such
as lipopolysaccharide (LPS) systemic injection or in SOD1mouse-
model of ALS (41, 42). On the other hand, P2ry12 and Fcrls con-
tinue to be expressed bymicroglia in EAE but are not expressed by
infiltrating monocytes (21). Therefore, further studies need to be
undertaken in order to better characterize these “new” phenotypic
microglia markers under pathological conditions.
Monocyte-Derived Microglia
Even though microglia homeostasis is maintained through local
self-renewal, under certain conditions circulating precursors can
give rise to microglia-like cells. For example, early studies using
BM-chimeras showed that up to 10–20% of microglia were recon-
stituted by donor-derived cells 6-12 months after total-body irra-
diation and BM transplantation (43). However, this engraftment
of BM-derived microglia can only be seen upon blood–brain-
barrier (BBB) disruption (e.g. irradiation) and becomes mini-
mal in models where the BBB is unperturbed (e.g. protection
of the head during irradiation and parabiosis) (44, 45). This
clearly indicates that under steady state conditions, monocytes
or BM-derived myeloid progenitors do not infiltrate the CNS
parenchyma and thus do not give rise to adult microglia. Sim-
ilarly, as described above in experimental models of neuro-
inflammation, monocytes infiltrate the CNS and differentiate
into effector cells resembling phenotypically activated microglia.
Despite these similarities, monocyte-derived cells do not persist
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in the CNS after inflammation has been resolved and thus do not
contribute to long-lived microglia (46).
Finally, local administration of ganciclovir to transgenic mice
expressing the thymidine kinase of herpes simplex virus under
the CD11b promoter (CD11b-HSVTK) leads to a rapid deple-
tion of microglia (47, 48). Subsequently, BM-derived cells enter
the CNS and differentiate into long-lived microglia-like cells.
Notably, while these cells form a network filling the niche for
embryonically derived microglia, they do not obtain a com-
plete microglia phenotype. Monocyte-derived “microglia” in this
model show a less-ramified morphology and a higher expres-
sion of CD45 compared to yolk sac-derived microglia resembling
more activated microglia (48). It has not yet been investigated
whether these monocyte-derived “microglia” functionally resem-
ble embryonically derived microglia or whether they acquire
microglia-signature genes (Siglec-H, Fcrls, P2ry12) as described
above.
Recent studies used a Csf-1R inhibitor to deplete microglia.
Upon treatment stop, microglia were repopulated within 1week
(49, 50). These studies showed that new “microglia” were derived
from CNS-resident nestin-positive precursors and resembled
embryonically derived microglia in response to an inflammatory
stimulus. Animals with newly repopulated “microglia” did not
display any impairment in behavior, cognition, or motor function
compared to control animals (50).
Monocytes and Monocyte-Derived Cells
in CNS Inflammation
Brain inflammation or “encephalitis” invariably results in a
reshaping of the myeloid cell populations inhabiting the CNS.
An inflammatory response brought on by either infection or
autoimmune manifestations results in a rapid increase in blood-
derived cellularity to this otherwise dormant site. Despite EAE
being fully dependent on T helper cells (51), the vast major-
ity of the inflammatory infiltrate seen in EAE is of myeloid
derivation. Two types of monocytes exist including the classi-
cal monocytes (Ly6ChiCCR2+CX3CR1lo) and the non-classical
monocytes (Ly6CloCCR2 CX3CR1hi). Here, we will only discuss
Ly6Chi monocytes given that during neuro-inflammation, this
is the subset recruited to the brain. Engraftment of phagocytes
derived from circulating CCR2+ monocytes has also been shown
in an AD mouse model (39). Ly6Chi monocytes egress from the
BM and cross the BBB in a CCR2-dependent manner (52, 53)
followed by their differentiation into macrophages/moDCs and
upregulation of a set of cell surface markers (e.g., MHCII, CD11c)
expressed on a wide variety of MPSmembers. Likewise, microglia
progressively alter their phenotype to resemble more classically
activated macrophages during CNS inflammation, infection, and
neuronal or myelin damage (54).
Ly6C+ monocytes were shown to migrate into the CNS
prior to disease onset and precede the development of paralysis
and subsequent clinical manifestations of EAE, when “DC-like”
cells are found in abundance in the inflamed tissue (55, 56).
This corresponds well with a previous report showing CD205+
myeloid cells accumulating in the meninges, choroid plexus, and
subpial space of the spinal cord and in perivascular cuffs in
demyelinating lesions during acute disease (57). CD11b+ DCs
within the inflamed CNS were demonstrated to be critical for the
propagation of EAE (27, 58, 59). Further phenotypical charac-
terization would be required to demarcate their lineage whether
they resemble moDCs or are more similar to classical DCs.
Indeed, monocyte-derived antigen presenting cells (APCs) have
been shown to be required for optimal priming of T cells in
models of infection (60). Current evidence suggests that phe-
notypically similar macrophages in the CNS can not only con-
tribute to the generation of inflammatory lesions and perform a
pathogenic role in the demyelination process but also contribute
to regenerative repair mechanisms to resolve inflammation (61,
62). These studies emphasize that distinct functions are attributed
to the different subsets of myeloid cells in the course of a CNS
inflammation. As such, a complete understanding of cell types
based on surface phenotype alone would be of great benefit both
in preclinical models of CNS inflammation and also in human
patients.
Even with the knowledge we now possess onmyeloid cell diver-
sity, it is still commonplace in the literature using animal models
of CNS inflammation to use a simplistic CD45hiCD11bhi gating
strategy to separate CNS infiltrating, blood-derived myeloid cells
from CNS-resident, embryonically derived microglia (CD45low)
(63). Efforts to sort cells using a broad CD45hiCD11bhi surface
phenotype from within the inflamed CNS will inevitably result
in analysis of multiple cell types, lacking any of the desired
specificity. Indeed, without the removal of Ly6Ghi cells during
sorting, a mixed population is inevitable and expression profiles
subsequently attributed to moDCs are either confused with, or
heavily influenced by, an abundant neutrophil contamination.
Even if the effort is taken to remove neutrophils, moDCs at
various stages of development will be incorporated. This dis-
tinction is increasingly important given that both neutrophils
and moDCs have been shown to mediate BBB permeability and
demyelination, and that different pathogenic mechanisms are
likely active in the two populations during the same inflamma-
tion (40, 64).
We know that at least four clearly distinct cell types share
this rather non-specific CD45hiCD11bhi surface phenotype in an
inflamed CNS, namely neutrophils (CD11b+Ly6G+), monocytes
(CD11b+Ly6ChiCX3CR1low), and their progeny such as moDCs
and/or activated macrophages (Figure 1). The latter two cell
types represent most likely the same population with just dif-
ferent names assigned by different studies. Ly6Chi monocytes
that have migrated into the CNS can further be subdivided into
numerous differentiation stages characterized by the upregula-
tion of CD11c and MHCII, with the concomitant downregu-
lation of Ly6C and CCR2. Upon differentiation and upregu-
lation of MHCII, monocytes are then called moDCs/activated
macrophages. Thus, moDCs in the CNS are characterized by the
expression of CD11b+F4/80+MHCII+CD11cintLy6C+/ . These
moDCs/activated macrophages also express CD64 and likely
also MerTK, which both are universally expressed by tissue
macrophages including microglia (19). Interestingly, it has been
shown that monocytes recruited to the CNS during EAE do
not express the newly identified microglia markers Fcrls and
P2ry12 highlighting again the diverse ontogeny of these cell types
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and suggesting that the microglia-signature genes are indeed
specific to microglia rather than location (CNS) specific (21).
The Fc"RIα (MAR-1) has been suggested to represent a moDC
marker. Whether moDCs in the inflamed CNS express MAR-
1 has so far not been analyzed (65). Perhaps a more functional
distinction should be drawn on the level of relevance for the
inflammatory process to persist. CNS-infiltrating myeloid cells
with DC-like morphology express MHCII, CD40, and CD86, all
of which have critical roles in multiple inflammatory models
(66). The CD86/CD28 interaction between T cells and APCs
is of critical importance for T cell activation. Furthermore, the
CD40/CD40L interaction induces a maturation pathway within
the inflamed CNS, resulting in further costimulatory capabilities
and proinflammatory cytokine expression (67, 68). The levels of
CD40 onmonocyte-derived cells in the inflamedCNS are variable
but generally not as high as on classical DCs.
After activation, inflammatory macrophages can not only
express a wide range of inflammatory cytokines but also oxygen-
based chemically reactive molecules involved in host defense. The
route an activated macrophage takes depends largely on the T
cell and/or NK cell-derived cytokines present during their acti-
vation. For example, activation in the presence of LPS and IFN-γ
leads to a “classical” activation (often called “M1”), resulting in
secretion of high levels of TNF-α, iNOS, IL-1, IL-6, and IL-12.
Conversely, activation of the same cells in the presence of IL-4
and IL-10 will result in rapid upregulation of IL-10, production
of Arginase-1, and upregulation of the mannose receptor CD206,
generating a macrophage capable of suppressing T cell activity
(called “M2”) (69). This intracellular divergence in phenotype
illustrates that an apparently similar cell expressing F4/80, CD64,
CD11b, MHCII, and CD11c on its surface may, in fact, differ
greatly in its function. Indeed, markers identifying both M1 and
M2 macrophage populations have been shown synergistically in
CNS biopsies obtained from MS patients. CD40, CD64, CD86,
and CD32, mannose receptor and CD163 were co-expressed
in the large majority of foamy macrophages found in lesional
CNS (70). Therefore, surface characterization of inflammatory
macrophages would appear insufficient and may mask differ-
ent macrophage populations in direct opposition to each other,
depending on the type of inflammation taking place. Generally
in the steady state, tissue macrophages display an “M2-like” phe-
notype and are critical for tissue homeostasis. Interestingly, in a
model of spinal cord injury, it was shown that M2 macrophages
(CD11b+F4/80+CX3CR1hiLy6Clo) are beneficial and promote
recovery (62).
Conclusion
Under steady state conditions, site specific and phenotypic char-
acteristics exist to distinguish between microglia and other CNS-
associated macrophages. As with almost all innate and adaptive
immune cell types, consensus with respect to nomenclature in
CNS-resident versus CNS-infiltrating myeloid cells has not been
effectively reached under inflammatory conditions. The advent
of microarray technology and next generation sequencing will
serve to provide more useful ways to distinguish between these
two apparently similar, yet ever more functionally diverse cell
types. An ever-increasing variety of previously unappreciated, and
non-immune homeostatic functions performed by macrophages
are now beginning to emerge, making a more detailed separa-
tion of these cell types highly desirable (71). Ultimately, better
characterization and dissection of the various myeloid cells in an
inflamed brain will help deciphering the specialized functions of
the different members of the MPS in pathological conditions.
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